UK biotech sector reports record year of investment
A record £3bn ($4bn) has been raised by the UK biotech and life science sector in the first three quarters of 2021.
Archives for October 11, 2021
Lonza invests in Singapore to support growth in mammalian biologics
Lonza is investing to expand mammalian development services at its Singapore facility; the move will bring additional capacity for cell culture, purification, and analytical services for mammalian biologics.
Samsung Biologics to help Enzolytics advance clinical development of mAbs
Samsung Biologics and Enzolytics have entered into a strategic CDMO partnership agreement targeting monoclonal antibody production.
Boehringer Ingelheim inaugurates Vienna production facility
Boehringer Ingelheim has inaugurated a state-of-the-art biopharmaceutical production facility in Vienna, Austria: representing the single largest investment in the company’s history.